Loading…
Contact Lens Rule Modernization Act
Legislative Progress
Introduced
September 17, 2020
Latest Action
September 17, 2020
Primary Sponsor
John BoozmanRepublican(AR)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,086 other S bills in the 116th — cohort avg 30d
Contact Lens Rule Modernization Act This bill (1) requires prescribers of contact lenses to conspicuously post notice that the prescriber is required to provide a copy of the contact lens prescription to the patient, (2) prohibits prescribers from requiring patients to acknowledge a contact lens prescription release in writing or electronically, and (3) prohibits automated telephone calls to verify a prescription.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (10)
Read twice and referred to the Committee on Commerce, Science, and Transportation.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2021 · first_quarter · Consumer Issues/Safety/Products
Administrative and legislative monitoring and outreach on issues related to the Federal Trade Commission's proposed Contact Lens Rule. Monitor issues related to counterfeit contact lenses. Monitor legislative activity related to the COVID-19 pandemic and the federal governments response to the outbreak. Legislative monitoring and outreach on issues related to the implementation of the Fairness to Contact Lens Consumers Act (P.L. 108-164). Legislative monitoring and outreach related to H.R. 1319, American Rescue Plan (P.L. 117-2). Legislative monitoring and outreach related to the H.R. 6058, SHOP SAFE Act of 2020. Legislative monitoring and outreach on issues related to S. 4613, Contact Lens Rule Modernization Act. Legislative monitoring and outreach on issues related to H.R. 3975, Contact Lens Prescription Verification Modernization Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2021 · first_quarter · Trade (domestic/foreign)
Administrative and legislative monitoring and outreach on issues related to the Federal Trade Commission's proposed Contact Lens Rule. Monitor issues related to counterfeit contact lenses. Monitor legislative activity related to the COVID-19 pandemic and the federal governments response to the outbreak. Legislative monitoring and outreach on issues related to the implementation of the Fairness to Contact Lens Consumers Act (P.L. 108-164). Legislative monitoring and outreach related to H.R. 1319, American Rescue Plan (P.L. 117-2). Legislative monitoring and outreach related to the H.R. 6058, SHOP SAFE Act of 2020. Legislative monitoring and outreach on issues related to S. 4613, Contact Lens Rule Modernization Act. Legislative monitoring and outreach on issues related to H.R. 3975, Contact Lens Prescription Verification Modernization Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2021 · first_quarter · Health Issues
Administrative and legislative monitoring and outreach on issues related to the Federal Trade Commission's proposed Contact Lens Rule. Monitor issues related to counterfeit contact lenses. Monitor legislative activity related to the COVID-19 pandemic and the federal governments response to the outbreak. Legislative monitoring and outreach on issues related to the implementation of the Fairness to Contact Lens Consumers Act (P.L. 108-164). Legislative monitoring and outreach related to H.R. 1319, American Rescue Plan (P.L. 117-2). Legislative monitoring and outreach related to the H.R. 6058, SHOP SAFE Act of 2020. Legislative monitoring and outreach on issues related to S. 4613, Contact Lens Rule Modernization Act. Legislative monitoring and outreach on issues related to H.R. 3975, Contact Lens Prescription Verification Modernization Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2021 · first_quarter · Health Issues
Administrative and legislative monitoring and outreach on issues related to the Federal Trade Commission's proposed Contact Lens Rule. Legislative monitoring and outreach on issues related to the Contact Lens Rule Modernization Act (S. 4613). Legislative monitoring and outreach on issues related to COVID-19 response. Legislative monitoring and outreach related to the implementation of H.R. 1319, American Rescue Plan (P.L. 117-2).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Consumer Issues/Safety/Products
Administrative and legislative monitoring and outreach on issues related to the Federal Trade Commission's proposed Contact Lens Rule. Legislative monitoring and outreach on issues related to the Contact Lens Rule Modernization Act (S. 4613). Legislative monitoring and outreach on issues related to COVID-19 response. Legislative monitoring and outreach related to the implementation of H.R. 1319, American Rescue Plan (P.L. 117-2).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
1) Maintain Taxpayers Against Illicit Opioids. No specific legislation. 2) For ensuring speedy access to new gene and cell therapies. No specific legislation. 3) Oppose efforts to remove consumer protections for contact lens wearers - S. 4613 4) Oppose importing foreign price controls through international reference pricing - S. 977, S. 102, H.R. 3 5) Oppose FDA graphic warning labels on cigarettes 6) Support increasing biosimilar adoption. No specific legislation. 7) Oppose banning flavored e-cigarettes. No specific legislation. 8) Oppose rate-setting on surprise medical bills - S. 1895 9) Support Independent Dispute Resolution for surprise medical bills - H.R. 3502 10) Oppose imposing International Pricing Index executive order. 11) Oppose expanding the Medicaid Drug Rebate Program - Docket No. CMS-2482-P 12) Support reforming telehealth and improving access to virtual care. No specific legislation.
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
2020 · fourth_quarter · Consumer Issues/Safety/Products
monitored implementation of FTC contact lens rule & legislation related to the rule -- including S. 4613 and HR 3975
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
HR 6663, Truth in Health Care Marketing Act P.L. 111-148 Affordable Care Act, modifications: 1. Reducing regulatory/costly burdens on medical practices - relief from regulatory burdens 2. Preserving patient access to office ancillary testing services Meaningful Use/EHR program issues P.L. 113-54, Drug Quality & Security Act, all sections Medicare Advantage plan network adequacy Prior authorization utilization policies Medicare Part B Drug Price Issues Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues Proposed Contact Lens Rule Modifications Medicare Physician Payment Issues Drug Pricing and Shortages Issues S. 2020, SEE MORE ACT Vision Research Funding Medical Surprise Billing Legislative proposals HR 3107, Improving Seniors' Timely Access to Care Act HR 3975, Contact Lens Prescription Verification Modernization Act S. 4613, Contact Lens Rule Modernization Act HR 2279/S.2546, Safe Step Act HR 4665, The Medicare Vision Act HR 3, Elijah Cummings Lower Drug Cost Now Act Coronavirus Pandemic Relief Measures HR 6365/S.3559 Immediate Relief for Rural Facilities and Providers Act HR 7059, Coronavirus Provider Protection Act HR 2620, Faster Treatments and Cures for Eye Diseases Act HR 7819, Eliminating the Provider Relief Fund Tax Penalties Act S. 4295, Public Health Emergency Pass-Through Payment Fairness Act HR 8624, Protecting Access to Innovation During COVID-19 Act S.4932, the Medicare Reimbursement Equity Act HR 8702/S. 5007, the Holding Providers Harmless From Medicare Cuts During COVID-19 Act HR 8505, a bill to waive budget neutrality requirements of the Medicare Physician Fee Schedule H.R. 8709, the Analyzing Kinetic Impact Projectiles (KIPs) Against Americans Act
Client expense: $210,000 · Firm income: Not reported
2020 · fourth_quarter · Health Issues
H.R. 3975 - Contact Lens Prescription Verification Modernization Act. S. 4613 - Contact Lens Rule Modernization Act.
Client expense: $200,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Consumer Issues/Safety/Products
H.R. 3975 Contact Lens Prescription Verification Modernization Act S. 4613 Contact Lens Rule Modernization Act.
Client expense: $400,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
Issues and legislative proposals related to contact lenses Issues related to the Federal Trade Commission Contact Lens Rule Issues related to HR3975 Contact Lens Prescription Verification Modernization Act Issues related to COVID-19 response. H.R. 6800, HEROES Act; H.R. 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act. Issues related to S. 4613, The Contact Lens Rule Modernization Act
Client expense: $350,000 · Firm income: Not reported
Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Consumer Issues/Safety/Products
Issues and legislative proposals related to contact lenses Issues related to the Federal Trade Commission Contact Lens Rule Issues related to HR3975 Contact Lens Prescription Verification Modernization Act Issues related to COVID-19 response. H.R. 6800, HEROES Act; H.R. 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act. Issues related to S. 4613, The Contact Lens Rule Modernization Act
Client expense: $350,000 · Firm income: Not reported
Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
- H.R. 863 - DXM Abuse Prevention Act of 2019, regarding all provisions - S. 726 - Personal Care Products Safety Act, regarding all provisions - Issues related to the regulation of over-the-counter drugs - Issues related to cosmetic regulatory reform - Issues related to cosmetic animal testing - Issues related to biosimilars - Issues related to maternal mortality - Issues related to contact lens safety - Issues related to medical product communications - Issues related to medical product review - Issues related to ingredient safety - Issues related to diversity in clinical trials - Issues related to health care pricing transparency - Issues related to peripheral artery disease - H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - Issues related to drug importation - S. 2543, "Prescription Drug Pricing Reduction Act of 2019", regarding all provisions - H.R. 19, "Lower Costs, More Cures Act of 2019", regarding all provisions - H.R. 748/ S. 3458, "'Coronavirus Aid, Relief, and. Economic Security Act'', regarding all provisions - H.R. 6074, "Coronavirus Preparedness and Response Supplemental Appropriations Act", regarding all provisions - H.R. 6201, "Families First Coronavirus Response Act", regarding all provisions - H.R. 3975, the Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 5663, the Safeguarding Therapeutics Act, regarding all provisions - Issues related to counterfeit health care goods - S. 3468, Preventing Essential Medical Device Shortages Act of 2020 - Issues related to counterfeit medical devices and combination products and authority to destroy counterfeit medical products - Issues related to reporting medical device shortages - Issues related to pandemic response - S. 2740, "Over the Counter Monograph Safety, Innovation, and Reform Act of 2019", regarding all provisions - H.R. 5279, "Cosmetic Safety Enhancement Act", regarding all provisions - H.R. 4296, "Safe Cosmetics and Personal Care Products Act of 2019", regarding all provisions - Issues related to social determinants of health - H.R. 5076/S. 1872, "Protecting Seniors Through Immunization", regarding all provisions - H.R.6062, "To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes", regarding all provisions. - H.R.6952, "To direct the President to appoint a Medical Supplies Response Coordinator to coordinate the efforts of the Federal Government regarding the supply and distribution of certain supplies and equipment relating to COVID-19", regarding all provisions - S.3942, "Securing America's Medical Supply Chain and Advancing the Production of Life Saving Medicines Act", regarding all provisions - S.3945, "Bring Entrepreneurial Advancements To Consumers Here In North America Act", regarding all provisions - S.3780, "HOME Act", regarding all provisions - S.3781, "PART Act", regarding all provisions - Issues related to diversity in clinical trials - Issues related to 340B - S.4613, The Contact Lens Rule Modernization Act, regarding all provisions - H.R.3107, "Improving Seniors Timely Access to Care Act of 2019, regarding all provisions - Executive Order 13948: Lowering Drug Prices by Putting America First - Executive Order 13939: Lowering Prices for Patients by Eliminating Kickbacks to Middlemen - Executive Order 13938: Increasing Drug Importation To Lower Prices for American Patients - Executive Order 13937: Access to Affordable Life-Saving Medications -H.R.133 - Consolidated Appropriations Act, 2021, including legislation regarding average sales price (ASP) reporting requirements for certain hyaluronic acid (HA) products that are classified as devices, but reimbursed as drugs under Medicare Part B
2020 · fourth_quarter · Consumer Issues/Safety/Products
S.4613 - Contact Lens Rule Modernization Act.
Client expense: Not reported · Firm income: $20,000
Government targets: SENATE
2020 · fourth_quarter · Health Issues
Administrative and legislative monitoring and outreach on issues related to the Federal Trade Commission's proposed Contact Lens Rule. Monitor issues related to counterfeit contact lenses. Monitor legislative activity related to the COVID-19 pandemic and the federal governments response to the outbreak. Legislative monitoring and outreach on issues related to the implementation of the Fairness to Contact Lens Consumers Act (P.L. 108-164). Legislative monitoring and outreach related to the implementation of The CARES Act (P.L. 116-136). Legislative monitoring and outreach on issues related to the HEALS Act (S. 4317 - S. 4324). Legislative monitoring and outreach on issues related to S.4613, the Contact Lens Rule Modernization Act. Legislative monitoring and outreach on issues related to H.R. 3975, Contact Lens Prescription Verification Modernization Act. Legislative monitoring and outreach on issues related to H.R. 7668, Financial Services and General Government Appropriations Act, 2021. Legislative monitoring and outreach on issues related to the FY2021 Omnibus and COVID Relief and Response Act (P.L. 116-260).
Client expense: Not reported · Firm income: $30,000
2020 · fourth_quarter · Consumer Issues/Safety/Products
Administrative and legislative monitoring and outreach on issues related to the Federal Trade Commission's proposed Contact Lens Rule. Monitor issues related to counterfeit contact lenses. Monitor legislative activity related to the COVID-19 pandemic and the federal governments response to the outbreak. Legislative monitoring and outreach on issues related to the implementation of the Fairness to Contact Lens Consumers Act (P.L. 108-164). Legislative monitoring and outreach related to the implementation of The CARES Act (P.L. 116-136). Legislative monitoring and outreach on issues related to the HEALS Act (S. 4317 - S. 4324). Legislative monitoring and outreach on issues related to S.4613, the Contact Lens Rule Modernization Act. Legislative monitoring and outreach on issues related to H.R. 3975, Contact Lens Prescription Verification Modernization Act. Legislative monitoring and outreach on issues related to H.R. 7668, Financial Services and General Government Appropriations Act, 2021. Legislative monitoring and outreach on issues related to the FY2021 Omnibus and COVID Relief and Response Act (P.L. 116-260).
Client expense: Not reported · Firm income: $30,000
2020 · fourth_quarter · Health Issues
Administrative and legislative monitoring and outreach on issues related to the Federal Trade Commission's proposed Contact Lens Rule. Legislative monitoring and outreach on issues related to COVID-19 response. Legislative monitoring and outreach related to the implementation of The CARES Act (P.L. 116-136). Legislative monitoring and outreach on issues related to the HEALS Act (S. 4317 - S. 4324). Legislative monitoring and outreach on issues related to the Contact Lens Rule Modernization Act (S.4613). Legislative monitoring and outreach on issues related to H.R.7668, Financial Services and General Government Appropriations Act, 2021. Legislative monitoring and outreach on issues related to the FY2021 Omnibus and COVID Relief and Response Act (P.L. 116-260).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Consumer Issues/Safety/Products
Administrative and legislative monitoring and outreach on issues related to the Federal Trade Commission's proposed Contact Lens Rule. Legislative monitoring and outreach on issues related to COVID-19 response. Legislative monitoring and outreach related to the implementation of The CARES Act (P.L. 116-136). Legislative monitoring and outreach on issues related to the HEALS Act (S. 4317 - S. 4324). Legislative monitoring and outreach on issues related to the Contact Lens Rule Modernization Act (S.4613). Legislative monitoring and outreach on issues related to H.R.7668, Financial Services and General Government Appropriations Act, 2021. Legislative monitoring and outreach on issues related to the FY2021 Omnibus and COVID Relief and Response Act (P.L. 116-260).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Consumer Issues/Safety/Products
S.1902, Stop Tip-overs of Unstable, Risky Dressers on Youth Act S.1858, CPSC CIO Parity Act S.4613, Contact Lens Rule Modernization Act S.3969, Aircraft Safety and Certification Reform Act of 2020 H.R.2211, STURDY Act H.R.3172, Safe Sleep for Babies Act of 2019 H.R.2, Moving Forward Act H.R.3248, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2019 Issues related to airline consumer protections and safety
Client expense: $10,000 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
2020 · fourth_quarter · Consumer Issues/Safety/Products
monitoring implementation of FTC contact lens rule & legislation related to the rule -- including S. 4613 and H.R. 3975
Client expense: Not reported · Firm income: Not reported
2020 · third_quarter · Health Issues
1) Maintain Taxpayers Against Illicit Opioids. No specific legislation. 2) For ensuring speedy access to new gene and cell therapies. No specific legislation. 3) Oppose efforts to remove consumer protections for contact lens wearers. S. 4613 4) Oppose importing foreign price controls through international reference pricing. S. 977, S. 102, H.R. 3 5) Oppose FDA graphic warning labels on cigarettes 6) Support increasing biosimilar adoption. No specific legislation. 7) Oppose banning flavored e-cigarettes. No specific legislation. 8) Oppose rate-setting on surprise medical bills. S. 1895 9) Oppose imposing International Pricing Index executive order. 10) Oppose expanding the Medicaid Drug Rebate Program. Docket No. CMS-2482-P 11) Support reforming telehealth and improving access to virtual care. No specific legislation.
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
2020 · third_quarter · Consumer Issues/Safety/Products
Administrative and legislative monitoring and outreach on issues related to the Federal Trade Commission's proposed Contact Lens Rule. Legislative monitoring and outreach on issues related to COVID-19 response. Legislative monitoring and outreach related to the implementation of The CARES Act (P.L. 116-136). Legislative monitoring and outreach on issues related to the HEALS Act (S. 4317 - S. 4324). Legislative monitoring and outreach on issues related to the Contact Lens Rule Modernization Act (S.4613). Legislative monitoring and outreach on issues related to H.R.7668, Financial Services and General Government Appropriations Act, 2021.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
Administrative and legislative monitoring and outreach on issues related to the Federal Trade Commission's proposed Contact Lens Rule. Legislative monitoring and outreach on issues related to COVID-19 response. Legislative monitoring and outreach related to the implementation of The CARES Act (P.L. 116-136). Legislative monitoring and outreach on issues related to the HEALS Act (S. 4317 - S. 4324). Legislative monitoring and outreach on issues related to the Contact Lens Rule Modernization Act (S.4613). Legislative monitoring and outreach on issues related to H.R.7668, Financial Services and General Government Appropriations Act, 2021.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Consumer Issues/Safety/Products
Issues and legislative proposals related to contact lenses Issues related to the Federal Trade Commission Contact Lens Rule Issues related to HR3975 Contact Lens Prescription Verification Modernization Act Issues related to COVID-19 response. H.R. 6800, HEROES Act; H.R. 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act. Issues related to S. 4613, The Contact Lens Rule Modernization Act
Client expense: $230,000 · Firm income: Not reported
Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
Issues and legislative proposals related to contact lenses Issues related to the Federal Trade Commission Contact Lens Rule Issues related to HR3975 Contact Lens Prescription Verification Modernization Act Issues related to COVID-19 response. H.R. 6800, HEROES Act; H.R. 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act. Issues related to S. 4613, The Contact Lens Rule Modernization Act
Client expense: $230,000 · Firm income: Not reported
Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
- H.R. 863 - DXM Abuse Prevention Act of 2019, regarding all provisions - S. 726 - Personal Care Products Safety Act, regarding all provisions - Issues related to the regulation of over-the-counter drugs - Issues related to cosmetic regulatory reform - Issues related to cosmetic animal testing - Issues related to biosimilars - Issues related to maternal mortality - Issues related to contact lens safety - Issues related to medical product communications - Issues related to medical product review - Issues related to ingredient safety - Issues related to diversity in clinical trials - Issues related to health care pricing transparency - Issues related to peripheral artery disease - H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - Issues related to drug importation - S. 2543, "Prescription Drug Pricing Reduction Act of 2019", regarding all provisions - H.R. 19, "Lower Costs, More Cures Act of 2019", regarding all provisions - H.R. 748/ S. 3458, "'Coronavirus Aid, Relief, and. Economic Security Act'', regarding all provisions - H.R. 6074, "Coronavirus Preparedness and Response Supplemental Appropriations Act", regarding all provisions - H.R. 6201, "Families First Coronavirus Response Act", regarding all provisions - H.R. 3975, the Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 5663, the Safeguarding Therapeutics Act, regarding all provisions - Issues related to counterfeit health care goods - S. 3468, Preventing Essential Medical Device Shortages Act of 2020 - Issues related to counterfeit medical devices and combination products and authority to destroy counterfeit medical products - Issues related to reporting medical device shortages - Issues related to pandemic response - S. 2740, "Over the Counter Monograph Safety, Innovation, and Reform Act of 2019", regarding all provisions - H.R. 5279, "Cosmetic Safety Enhancement Act", regarding all provisions - H.R. 4296, "Safe Cosmetics and Personal Care Products Act of 2019", regarding all provisions - Issues related to social determinants of health - H.R. 5076/S. 1872, "Protecting Seniors Through Immunization", regarding all provisions - H.R.6062, "To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes", regarding all provisions. - H.R.6952, "To direct the President to appoint a Medical Supplies Response Coordinator to coordinate the efforts of the Federal Government regarding the supply and distribution of certain supplies and equipment relating to COVID-19", regarding all provisions - S.3942, "Securing America's Medical Supply Chain and Advancing the Production of Life Saving Medicines Act", regarding all provisions - S.3945, "Bring Entrepreneurial Advancements To Consumers Here In North America Act", regarding all provisions - S.3780, "HOME Act", regarding all provisions - S.3781, "PART Act", regarding all provisions - Issues related to diversity in clinical trials - Issues related to 340B - S.4613, The Contact Lens Rule Modernization Act, regarding all provisions - H.R.3107, "Improving Seniors Timely Access to Care Act of 2019, regarding all provisions - Executive Order 13948: Lowering Drug Prices by Putting America First - Executive Order 13939: Lowering Prices for Patients by Eliminating Kickbacks to Middlemen - Executive Order 13938: Increasing Drug Importation To Lower Prices for American Patients - Executive Order 13937: Access to Affordable Life-Saving Medications
2020 · third_quarter · Health Issues
H.R. 3975 - Contact Lens Prescription Verification Modernization Act. S. 4613 - Contact Lens Rule Modernization Act.
Client expense: $130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Consumer Issues/Safety/Products
Administrative and legislative monitoring and outreach on issues related to the Federal Trade Commission's proposed Contact Lens Rule. Monitor issues related to counterfeit contact lenses. Monitor legislative activity related to the COVID-19 pandemic and the federal governments response to the outbreak. Legislative monitoring and outreach on issues related to the implementation of the Fairness to Contact Lens Consumers Act (P.L. 108-164). Legislative monitoring and outreach related to the implementation of The CARES Act (P.L. 116-136). Legislative monitoring and outreach on issues related to the HEALS Act (S. 4317 - S. 4324). Legislative monitoring and outreach on issues related to S.4613, the Contact Lens Rule Modernization Act. Legislative monitoring and outreach on issues related to H.R. 3975, Contact Lens Prescription Verification Modernization Act. Legislative monitoring and outreach on issues related to H.R. 7668, Financial Services and General Government Appropriations Act, 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
Administrative and legislative monitoring and outreach on issues related to the Federal Trade Commission's proposed Contact Lens Rule. Monitor issues related to counterfeit contact lenses. Monitor legislative activity related to the COVID-19 pandemic and the federal governments response to the outbreak. Legislative monitoring and outreach on issues related to the implementation of the Fairness to Contact Lens Consumers Act (P.L. 108-164). Legislative monitoring and outreach related to the implementation of The CARES Act (P.L. 116-136). Legislative monitoring and outreach on issues related to the HEALS Act (S. 4317 - S. 4324). Legislative monitoring and outreach on issues related to S.4613, the Contact Lens Rule Modernization Act. Legislative monitoring and outreach on issues related to H.R. 3975, Contact Lens Prescription Verification Modernization Act. Legislative monitoring and outreach on issues related to H.R. 7668, Financial Services and General Government Appropriations Act, 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Consumer Issues/Safety/Products
H.R. 3975 Contact Lens Prescription Verification Modernization Act S. 4613 Contact Lens Rule Modernization Act.
Client expense: $300,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Republican |
| OK |
| James M. Inhofe | Republican | OK |
| Jerry Moran | Republican | KS |
| Joe Manchin, III | Independent | WV |
| John Barrasso | Republican | WY |
| John Kennedy | Republican | LA |
| Kevin Cramer | Republican | ND |
| Kyrsten Sinema | Independent | AZ |
| Lisa Murkowski | Republican | AK |
| Mike Rounds | Republican | SD |
| Rand Paul | Republican | KY |
| Roger F. Wicker | Republican | MS |
| Shelley Moore Capito | Republican | WV |
| Susan M. Collins | Republican | ME |
| Tim Scott | Republican | SC |
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $1,450,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $860,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office